Crossmark

Intragastric Balloon in Obese Compensated Nonalcoholic Steatohepatitis Cirrhosis Patients Is Safe and Achieves Significant Weight Reduction at 6-Months

Crossref DOI link: https://doi.org/10.1007/s10620-022-07596-4

Published Online: 2022-06-28

Published Print: 2023-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Vijayaraghavan, Rajan

Sarin, Shiv K. https://orcid.org/0000-0002-0544-5610
Bharadwaj, Ankit

Anand, Lovkesh

Maiwall, Rakhi

Choudhury, Ashok

Benjamin, Jaya

Kanal, Uma

Jamwal, Kapil Dev
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct03753438 at ClinicalTrials.gov

Documents that mention this clinical trial

Intragastric Balloon in Obese Compensated Nonalcoholic Steatohepatitis Cirrhosis Patients Is Safe and Achieves Significant Weight Reduction at 6-Months
https://doi.org/10.1007/s10620-022-07596-4
License Information

Text and Data Mining valid from 2022-06-28

Version of Record valid from 2022-06-28
More Information

Article History

Received: 11 August 2021

Accepted: 31 May 2022

First Online: 28 June 2022

Declarations

:

: The authors disclose no competing interests.

: None.

Document is current

Any future updates will be listed below